| HPN |
HPN, TMPRSS1: Serine protease hepsin |
TST |
TST: Thiosulfate sulfurtransferase |
0.41 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
HAMP |
HAMP, HEPC, UNQ487/PRO1003, LEAP1: Hepcidin precursor |
0.41 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
ORM2 |
ORM2, AGP2: Alpha-1-acid glycoprotein 2 precursor |
0.41 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
C8G |
C8G: Complement component C8 gamma chain precursor |
0.41 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
0.41 |
Evidence |
|
| HRG |
HRG: Histidine-rich glycoprotein precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| HRG |
HRG: Histidine-rich glycoprotein precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.41 |
Evidence |
|
| RNASE4 |
ANG, RNASE5: Angiogenin precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| RNASE4 |
ANG, RNASE5: Angiogenin precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.41 |
Evidence |
|
| AFP |
AFP, HPAFP: Alpha-fetoprotein precursor |
SLC2A2 |
SLC2A2, GLUT2: Solute carrier family 2, facilitated glucose transporter member 2 |
0.41 |
Evidence |
|
| AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.41 |
Evidence |
|
| ORM1 |
ORM1, AGP1: Alpha-1-acid glycoprotein 1 precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| ORM1 |
ORM1, AGP1: Alpha-1-acid glycoprotein 1 precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.41 |
Evidence |
|
| AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| SLC4A1 |
SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein |
SPTA1 |
SPTA1, SPTA: Spectrin alpha chain, erythrocyte |
0.41 |
Evidence |
|
| APOC3 |
APOC3: Apolipoprotein C-III precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| APOC3 |
APOC3: Apolipoprotein C-III precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.41 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.41 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
0.41 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
0.41 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
0.41 |
Evidence |
|
| CGB |
CGB, CGB3, CGB5, CGB7, CGB8: Choriogonadotropin subunit beta precursor |
ADAM12 |
IPI00643672 |
0.41 |
Evidence |
|